Faculty profile

Mark Harrison

ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Mark Harrison

Researcher

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
45 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2022.
Supervised 5 trainees who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Climate And Health Equity Social Determinants Of Health Clinician Interviews Decisional Needs Assessment Discrete-Choice Experiment Heart Failure Medications

Latest papers

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.
Pharmacoepidemiology and drug safety · 2026 · first author
Patterns of X-Linked Retinitis Pigmentosa Genetic Testing in England and Implications for Service Provision.
Ophthalmology science · 2026
Can Patient-Reported Outcome Measures Help Predict Unplanned Hospital Readmission?
Medical care · 2026

All 82 publications

Latest funding

Improving PAtient Recruitment into Trials by elICIting Preferences And TradE-offs in Heart Failure (I-PARTICIPATE-HF).
CIHR · 2026 · Co-investigator
$100,000
Prioritization of Shared Decision-Making Opportunities Within the Context of Heart Failure with Reduced Ejection Fraction Medication Choices
CIHR · 2024 · Supervisor
$120,000
Applying an equity and intersectionality lens to understanding the burden of arthritis on aging Canadians (APPROACH)
CIHR · 2023 · Co-investigator
$69,094

All 19 grants and awards

82 publications.

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Harrison M, Blitz S, Law M, Tadrous M, Gomes T, Clement F, Rosenfeld G, Anis A, Bansback N

Pharmacoepidemiology and drug safety2026First author

DOI: 10.1002/pds.70395 PMID: 42157439

Patterns of X-Linked Retinitis Pigmentosa Genetic Testing in England and Implications for Service Provision.

Yates S, Whittaker W, Harrison M, Bayliss S, Barton S, Sergouniotis PI, Payne K, Black G

Ophthalmology science2026

DOI: 10.1016/j.xops.2026.101180 PMID: 42064015

Can Patient-Reported Outcome Measures Help Predict Unplanned Hospital Readmission?

Yu M, Harrison M, Wong H, Trenaman L, Bryan S, Lix L, Sawatzky R, Cuthbertson L, Al Sayah F, Bansback N

Medical care2026

DOI: 10.1097/mlr.0000000000002315 PMID: 41861120

Intersecting Social Identities and Health in Arthritis: A Latent Class Analysis of the Canadian Longitudinal Study on Aging.

Thomas MM, Sayre EC, Harrison M, Barnabe C, Ronquillo CE, Avina-Zubieta JA, Samson A, Kuluva M, Trehan N, Bhatti N, De Vera MA

ACR open rheumatology2026

DOI: 10.1002/acr2.90038 PMID: 42055048

Association of ischaemic stroke/TIA with subsequent oral anticoagulant adherence in patients with atrial fibrillation: a scoping review.

Shukkoor AA, Turgeon RD, De Vera MA, Harrison M, George NE, Loewen PS

BMJ open2026

DOI: 10.1136/bmjopen-2025-112736 PMID: 42331577

The relative value of mental health for pandemic response: A discrete choice experiment with stakeholders and the general population in Europe.

Lorant V, Nicaise P, Silva Ribeiro W, Harrison M, Park AL, McDaid D

Social science & medicine (1982)2026

DOI: 10.1016/j.socscimed.2026.119067 PMID: 41719730

Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study.

Cheng V, Sayre EC, Amiri N, Cragg JJ, Harrison M, Proulx L, De Vera MA

Journal of autoimmunity2026

DOI: 10.1016/j.jaut.2026.103538 PMID: 41780201

"What do you want this information for?": cognitive interviews with arthritis researchers to inform the development of a health equity-focused demographic survey for outcomes research.

Thomas MM, Oveisi N, Ronquillo CE, Harrison M, Barnabe C, Primeau C, Avina-Zubieta JA, Samson A, Kuluva M, Trehan N, Bhatti N, Methi A, De Vera MA

BMC rheumatology2026

DOI: 10.1186/s41927-026-00614-2 PMID: 41680860

Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Dang H, Blitz S, Bansback N, Law M, Harrison M

Arthritis care & research2026Senior author

DOI: 10.1002/acr.25610 PMID: 41131425

"It's Just Good Science": A Qualitative Study Exploring Equity, Diversity, and Inclusion in Canadian Arthritis Research.

Thomas MM, Harrison M, Barnabe C, Ronquillo CE, Avina-Zubieta JA, Samson A, Kuluva M, Trehan N, De Vera MA

Arthritis care & research2025

DOI: 10.1002/acr.25487 PMID: 39726224

Something wrong or missing on this profile? Suggest a correction

Mark Harrison

Research

Latest papers

Latest funding

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Patterns of X-Linked Retinitis Pigmentosa Genetic Testing in England and Implications for Service Provision.

Can Patient-Reported Outcome Measures Help Predict Unplanned Hospital Readmission?

Intersecting Social Identities and Health in Arthritis: A Latent Class Analysis of the Canadian Longitudinal Study on Aging.

Association of ischaemic stroke/TIA with subsequent oral anticoagulant adherence in patients with atrial fibrillation: a scoping review.

The relative value of mental health for pandemic response: A discrete choice experiment with stakeholders and the general population in Europe.

Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study.

"What do you want this information for?": cognitive interviews with arthritis researchers to inform the development of a health equity-focused demographic survey for outcomes research.

&#x200b;Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

"It's Just Good Science": A Qualitative Study Exploring Equity, Diversity, and Inclusion in Canadian Arthritis Research.

Frequent collaborators

Marie Hudson

Sarah Munro

Stirling Bryan

Cheryl Barnabe

Megan Thomas

Cheryl Koehn

Mohsen Sadatsafavi

Judy Illes

Aslam Anis

Larry Lynd

Kimberlyn McGrail

Mina Tadrous

Laurie Proulx

Glory Apantaku

Carlo Marra

Fiona Clement

Michael Law

Kathleen Elizabeth Wheeler

Stuart Peacock

Clare Wenham

Rosemin Kassam

Anshula Ambasta

Irene Ma

Tetyana Kendzerska

Hubert Wong

Susan Rogers Van Katwyk

Caley Shukalek

Niki Oveisi

Carol Hitchon

Deirdre McCaughey

Anshula Ambasta

Richard Sawatzky

John Esdaile

Sasha Bernatsky

Richard Sawatzky

Lisa Lix

Nicole Tsao

Jacek Kopec

Gordon Guyatt

Tyler Williamson

Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?